[HTML][HTML] Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - nature.com
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies,–. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay …
therapies,–. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay …
Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - ideas.repec.org
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
[PDF][PDF] Ebola virus antibody decay-stimulation in a high proportion of 2 survivors 3
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - core.ac.uk
Neutralizing antibody (nAb) function provides a foundation for vaccine and therapeutic 39
efficacy (1-3). Utilising a robust in vitro Ebola Virus (EBOV) pseudo-particle infection assay …
efficacy (1-3). Utilising a robust in vitro Ebola Virus (EBOV) pseudo-particle infection assay …
Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - archive.lstmed.ac.uk
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies1, 2, 3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies1, 2, 3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
Ebola virus antibody decay–stimulation in a high proportion of survivors
Ebola-CP Consortium - Nature, 2021 - kclpure.kcl.ac.uk
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - econpapers.repec.org
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
Ebola virus antibody decay-stimulation in a high proportion of survivors.
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - 2021 - cabidigitallibrary.org
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay …
therapies. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay …
Ebola virus antibody decay-stimulation in a high proportion of survivors.
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - europepmc.org
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
[HTML][HTML] Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - ncbi.nlm.nih.gov
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
[PDF][PDF] Ebola virus antibody decay–stimulation in a high proportion of survivors
C Adaken, JT Scott, R Sharma, R Gopal, S Dicks… - Nature, 2021 - academia.edu
Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …
therapies 1–3. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection …